课题基金 / 基金详情

Neuroprotection in models of retinal ganglion cell death

Neuroprotection in models of retinal ganglion cell death
视网膜神经节细胞死亡模型的神经保护作用
批准号：
224747
负责人：
Saragovi Horacio U
金额：
$51.24万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-03-01 至 2015-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=224747&lang=en
关键词：
Drug Development Glaucoma In Vivo Models Of Disease Neuroprotection Neurotoxicity Neurotrophin Receptor Retina Target Validation

项目摘要

项目成果

Saragovi Horacio U的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Glaucoma is defined as a special form of death of specialized neurons in the retina, called retinal ganglion cells (RGCs). Glaucoma is often associated with high pressure in the eye. The RGCs die in a progressive manner. These neurons transmit visual sign
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of effective targeted anti-GD2 cancer immunotherapies, that synergize with immune-checkpoint inhibitor blockades
Innovation of Proprietary Liquid Biopsy Assays for Diagnosis of Early Stage Ovarian Cancer
Innovation of a Proprietary Liquid Biopsy Strategy for Diagnosis of Early Stage Ovarian Cancer
Elucidating the paradox of TrkC receptor isoforms causing either neuronal survival or degeneration: target validation and therapeutic rationale using isoform-selective pharmacological and biological tools.
海外基金